|
ÀÀ±Þ½ÇER Æó·Å, COPD »ç·Ê¿¬±¸º¸°í¼, Critical Pathway / ¥°. ¼·Ð 1. »ç·Ê ¼±Á¤ÀÌÀ¯ 2. Åë°èÀû ÀÚ·á ¥±. ¹®Çå°íÂû - Áúȯ¸í, Á¤ÀÇ, ¿øÀÎ, Áõ»ó. Áø´Ü. Ä¡·á, °£È£ ¥². Critical Pathway 1. Medical Diagnosispneumonia 2. C.C 3. Present Illness(PI) 4. Past History 5. Assessments 6. Tests 7. Psychosocial Status 8. Nursing Diagnoses 9. Treatment 10. Medicat¡¦ |
|
|
|
|
|
¿©¼º°£È£ÇÐ critical thinking / 1.°ú ¸ñ ¸í 2.ÇнÀÁÖÁ¦ 3. °£È£»ç´Â À̾ç°ú ¾î¶»°Ô À̾߱⸦ ½ÃÀÛÇÒ±î 4. ÇÇÀÓÀ» À§ÇØ °Ç°°ü¸® Á¦°øÀÚ¸¦ ¹æ¹®ÇÏ´Â °Í¿¡ ´ëÇØ °£È£»ç´Â ¾î¶² ¸»À» ÇØÁÙ ¼ö ÀÖÀ»±î 5. °£È£»ç´Â Äܵ¼ »ç¿ë¿¡ ´ëÇØ ¹«¾ùÀ» ³íÀÇÇØ¾ß ÇÒ±î / 1.°ú ¸ñ ¸í ¿©¼º°£È£ÇÐÀº ¿©¼ºÀÇ »ý¸®Àû, ½É¸®Àû, »çȸÀû Ư¼ºÀ» ÀÌÇØÇÏ°í À̸¦ ¹ÙÅÁÀ¸·Î ÀûÀýÇÑ °£È£¸¦ Á¦°øÇÏ´Â Çй®ÀÌ´Ù. ¡¦ |
|
|
|
|
|
¹°¸®ÈÇнÇÇè °è¸éÈ°¼ºÁ¦(surfactants)ÀÇ Critical Micelle Concentration(CMC) ÃøÁ¤ °á°úº¸°í¼ / 1. Á¦¸ñ 2. ½ÇÇè °á°ú 1) ¼ö¿ë¾×°ú ¹Ì¼¿¿ë¾×¿¡¼ ¾òÀº BZAÀÇ UV Èí¼ö ½ºÆåÆ®·³(Èí±¤µµ vs ÆÄÀå)À¸·ÎºÎÅÍ enol°ú keto forms¿¡ ±âÀÎÇÏ´Â µÎ Èí¼ö¶ìÀÇ ÃÖ´ëÈí¼öÆÄÀåÀ» ±¸ÇÑ´Ù. 2) °¢ ½Ã·á ¿ë¾×ÀÇ Èí¼ö ½ºÆåÆ®·³¿¡¼ ¾Õ¿¡¼ °áÁ¤ÇÑ µÎ ÃÖ´ëÈí¼öÆÄÀå, lambda_{max}(enol)°ú lambda_{max}¡¦ |
|
|
|
|
|
·Î·»Áî(Lorenz)ÀÇ °¢ÀÎÇö»ó¿¡¼ °áÁ¤Àû½Ã±â(critical period)` °³³ä ÀÌÇØ / ¥°. ¼·Ð ¥±. º»·Ð 1. °¢ÀÎ ¹× °áÁ¤Àû ½Ã±â 2. °áÁ¤Àû ½Ã±â ÀÌÈÄ Å¸ÀΰúÀÇ °ü°è Çü¼º 3. ±³»ç·Î¼ÀÇ °áÁ¤Àû ½Ã±â ¥². °á·Ð ¥³. Âü°í¹®Çå / ¥°. ¼·Ð ·Î·»ÁîÀÇ °¢ÀÎÇö»óÀº µ¿¹° ÇൿÇп¡¼ Áß¿äÇÑ °³³äÀ¸·Î, ƯÈ÷ »õ³¢ µ¿¹°ÀÌ Æ¯Á¤ÇÑ °´Ã¼³ª °³Ã¼¿¡ ´ëÇØ °ÇÑ ¾ÖÂøÀ» Çü¼ºÇÏ´Â °úÁ¤À» ¼³¸íÇÑ´Ù. ÀÌ ¡¦ |
|
|
|
|
|
°ÇÃà°ø»çÀÇ CFF(Critical Failure Factors)¿Í ÇعýÀÇ ÀÌÇØ / 1. ºñ°è °ø»ç 2. È븷ÀÌ °ø»ç 3. ±âÃÊ °ø»ç 4. ö±ÙÄÜÅ©¸®Æ® °ø»ç 5. Ä¿Æ°¿ù °ø»ç 6. ´Ü¿ °ø»ç 7. ¹æ¼ö °ø»ç 8. ¼Ò°¨¹® / 1. ºñ°è °ø»ç ºñ°è °ø»ç´Â °ÇÃà°ø»ç¿¡¼ Áß¿äÇÑ ºÎºÐÀ» Â÷ÁöÇÑ´Ù. ºñ°è´Â ÀÛ¾÷ÀÚ°¡ ³ôÀº °÷¿¡¼ ¾ÈÀüÇÏ°Ô ÀÛ¾÷ÇÒ ¼ö ÀÖµµ·Ï ÇØÁÖ¸ç, Àüü °ø»çÀÇ ¾ÈÀü¼º°ú Ç°ÁúÀ» º¸ÀåÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. ÇÏÁö¡¦ |
|
|
|
|
|
[´Ü±¹´ë] Critical Speed ½ÇÇè ·¹Æ÷Æ® A£« / 1. ½ÇÇè ¿ä¾à 1.1½ÇÇè ¸ñÀû 2. ½ÇÇè ÀÌ·Ð 2.1ºñ°¨¼è °Á¦ Á¶È Áøµ¿ 2.2ȸÀüÃà°èÀÇ ºÒÆòÇü Áú·®¿¡ ÀÇÇÑ Áøµ¿ 3. ½ÇÇèÀåÄ¡ 3.1 ½ÇÇèÀåÄ¡ 3.2 ½ÇÇè °è»ê½Ä 4. ½ÇÇè ¹æ¹ý 5. ÁÖÀÇ »çÇ× 6. ½ÇÇè°á°ú 6.1 ½ÇÇè°á°ú 6.2 ÀÌ·Ð 7. ¿ë¾î Á¤¸® 8. °íÂû 9. Âü°í¹®Çå / 1. ½ÇÇè ¿ä¾à Critical Speed ½ÇÇèÀº ¹°Ã¼ÀÇ È¸Àü ¿îµ¿¿¡¡¦ |
|
|
|
|
|
ICH ÀÀ±Þ½Ç ÄÉÀ̽º ½ºÅ͵ð(Critical pathway) / ¨ç Daily outcomes ¨è Assessments ¨é Tests ¨ê Treatment ¨ë Medication Âü°í¹®Çå / ¨ç Daily outcomes Emergency departmentÀÇ daily outcomes´Â ȯÀÚ Ä¡·áÀÇ Áú°ú È¿À²¼ºÀ» Æò°¡ÇÔ¿¡ ÀÖ¾î ÇÙ½ÉÀûÀÎ ¿ä¼Ò´Ù. ÀÌ outcomes´Â ȯÀÚÀÇ ¾ÈÀü¼º°ú Ä¡·á ¼º°ú¸¦ ÃøÁ¤Çϸç, ÀÇ·á ¼ºñ½º°¡ Á¦°øµÇ´Â °úÁ¤¿¡¼ ¹ß»ýÇÏ´Â ´Ù¾çÇÑ ÁöÇ¥¸¦ Æ÷ÇÔ¡¦ |
|
|
|
|
|
Critical Thinking °úÁ¦(´ëü°úÁ¦) / (1) There are several risk factors for coronary artery disease (CAD). For each risk factor listed, mark whether it is non-modifiable or modifiable. (2) Circle the non-modifiable and modifiable risk factors that apply to Thomas. (3) Which lab values are of concern at this time Explain your answers. (4) Thomas asks you, ¡°¡¦ |
|
|
|
|
|
¥°. ¼·Ð ·Î·»ÁîÀÇ °¢ÀÎÇö»óÀº µ¿¹° ÇൿÇп¡¼ Áß¿äÇÑ °³³äÀ¸·Î, ƯÁ¤ »ý¹°Ã¼°¡ ÅÂ¾î³ ÈÄ °¡Àå ¹Î°¨ÇÑ ½Ã±â¿¡ ƯÁ¤ÇÑ ´ë»óÀ» ÀνÄÇÏ°í ±× ´ë»óÀ».. / ¥°. ¼·Ð ¥±. º»·Ð 1. °¢ÀÎ ¹× °áÁ¤Àû ½Ã±â 2. °áÁ¤Àû ½Ã±â ÀÌÈÄ Å¸ÀΰúÀÇ °ü°è Çü¼º 3. ±³»ç·Î¼ÀÇ °áÁ¤Àû ½Ã±â ¥². °á·Ð ¥³. Âü°í¹®Çå / ¥°. ¼·Ð ·Î·»ÁîÀÇ °¢ÀÎÇö»óÀº µ¿¹° ÇൿÇп¡¼ Áß¿äÇÑ °³³äÀ¸·Î, ƯÁ¤ »ý¹°Ã¼°¡¡¦ |
|
|
|
|
|
¥°. ¼·Ð ·Î·»ÁîÀÇ °¢ÀÎÇö»óÀº µ¿¹° ÇൿÇп¡¼ Áß¿äÇÑ °³³äÀ¸·Î, ƯÁ¤ »ý¹°Ã¼°¡ ÅÂ¾î³ ÈÄ °¡Àå ¹Î°¨ÇÑ ½Ã±â¿¡ ƯÁ¤ÇÑ ´ë»óÀ» ÀνÄÇÏ°í ±× ´ë»óÀ».. / ¥°. ¼·Ð ¥±. º»·Ð 1. °¢ÀÎ ¹× °áÁ¤Àû ½Ã±â 2. °áÁ¤Àû ½Ã±â ÀÌÈÄ Å¸ÀΰúÀÇ °ü°è Çü¼º 3. ±³»ç·Î¼ÀÇ °áÁ¤Àû ½Ã±â ¥². °á·Ð ¥³. Âü°í¹®Çå / ¥°. ¼·Ð ·Î·»ÁîÀÇ °¢ÀÎÇö»óÀº µ¿¹° ÇൿÇп¡¼ Áß¿äÇÑ °³³äÀ¸·Î, ƯÁ¤ »ý¹°Ã¼°¡¡¦ |
|
|
|
|